vaccinia-CEA vaccine

Also Known As:

rV-CEA vaccine

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 01/01/1996 - "The results of these studies showed the rV-CEA vaccine to be immunogenic and safe in both rodents and primates, and to elicit good anti-tumor responses in the rodent model. " 01/01/1996 - "Thus, in a Phase I clinical trial the rV-CEA vaccine has been shown to stimulate a CTL response specific for CEA defined epitopes in cancer patients."
2.	Adenocarcinoma 09/01/1999 - "No objective clinical responses to the rV-CEA vaccine were observed among this population of patients with widely metastatic adenocarcinoma."

1.	Epitopes